Skip to main content
. 2024 Jun 13;12(6):1320. doi: 10.3390/biomedicines12061320

Figure 5.

Figure 5

Clinical trials of subcutaneous semaglutide in overweight and obese individuals to evaluate weight loss efficacy (STEP 1–6, STEP-8, STEP Teens, STEP HFpEF).